Advanced Code injection
0

Access funding, mentorship, commercialization support, and a powerful innovation network by becoming an OBIO® member today!

Skip to Content
OBIO
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Women in Health Initiative
Skills Development & Training
Critical Technologies
Advocacy Efforts
Defence & Dual-Use
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
OBIO
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Women in Health Initiative
Skills Development & Training
Critical Technologies
Advocacy Efforts
Defence & Dual-Use
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
Folder: About
Back
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
Folder: Areas of Focus
Back
At a Glance
Capital Access & Adoption
Women in Health Initiative
Skills Development & Training
Critical Technologies
Advocacy Efforts
Defence & Dual-Use
Folder: Events
Back
All Events
OBIO Investment Summit
Folder: News
Back
News & Press Releases
Tariff Relief Resources
Folder: Membership
Back
Membership
Member Log in
Job Board
OBIO News, Ontario Industry Updates Arsheen Kaur 11/17/26 OBIO News, Ontario Industry Updates Arsheen Kaur 11/17/26

Allarta Life Science moves Canadian-developed Type 1 Diabetes Cell Therapy Closer to the Clinic

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/17/26 OBIO News, Ontario Industry Updates Arsheen Kaur 11/17/26

Help Ontario’s Biomanufacturing Workforce use AI with Judgement

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/3/26 OBIO News, Ontario Industry Updates Arsheen Kaur 11/3/26

Specific Biologics Announces Oversubscribed US$35 Million Series A Financing to Advance Gene-Editing Therapy for ALS

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/3/26 OBIO News, Ontario Industry Updates Arsheen Kaur 11/3/26

Fibra Brings Health Tracking to Underwear

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/29/26 OBIO News, Ontario Industry Updates Arsheen Kaur 10/29/26

Minister Joly Unveils Canada’s New Venture and Growth Capital Plan that will Strengthen Venture Capital Investments in Canada with $1.75 Billion in Funding

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/21/26 OBIO News, Ontario Industry Updates Arsheen Kaur 10/21/26

Deep Breathe Receives $1M Investment from FedDev Ontario

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/21/26 OBIO News, Ontario Industry Updates Arsheen Kaur 10/21/26

Genesys Capital Announces Second Close of Genesys University Seed Fund

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/21/26 OBIO News, Ontario Industry Updates Arsheen Kaur 10/21/26

Toronto Robotics Start-up Hopes to Expand Options for Surgical Procedures

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/6/26 OBIO News, Ontario Industry Updates Arsheen Kaur 10/6/26

Vasomune Therapeutics Completes Enrollment of Phase 2a Study of Pegevongitide (AV-001) in Patients Hospitalized with Pneumonia/ARDS

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/30/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/30/26

Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/30/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/30/26

Government of Canada Invests in 10,000 AI-related Work Placements for Young Canadians

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26

File your Accessibility Compliance Report (ACR) by December 31, 2026

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26

Stem Cell Network makes First Direct Biotech Investment, Awarding $1 Million to Montreal-based RejuvenRx

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26

QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/22/26

Capital BioVentures Launches ASCENT26: Accelerating Canada’s Next Therapeutic Breakthroughs

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/9/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/9/26

RBC to Mobilize $1.4 billion to Back Canada's Next Global Technology Champions and Advance Nation-Building Efforts

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/8/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/8/26

AI-Fundamentals for the Bio-Economy

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/8/26 OBIO News, Ontario Industry Updates Arsheen Kaur 9/8/26

Ripple Therapeutics Wins the 2026 Gold Leaf Award for Promising Biotech Company of the Year

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/25/26 OBIO News, Ontario Industry Updates Arsheen Kaur 8/25/26

Ontario Commercialization Partnership Fills Critical Gap for Women Entrepreneurs and Advances Cancer Discoveries

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/25/26 OBIO News, Ontario Industry Updates Arsheen Kaur 8/25/26

Supply Ontario Expands Access to Made-in-Ontario Innovation for Ontario’s Health Sector

Read More
Older Posts
Become an OBIO® Member Today!

Contact us:

OBIO®
101 College St., Suite HL50

Toronto, ON M5G 1L7

OBIO © 2026

(416) 848 6839
info@obio.ca

Media Kit

NEWSlETTER Sign UP

Terms & Conditions